Nuo Therapeutics, Inc. Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Nuo Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Nuo Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -347 %, a 17.8% decline year-over-year.
  • Nuo Therapeutics, Inc. annual Return On Equity for 2023 was -355 %, a 164% decline from 2022.
  • Nuo Therapeutics, Inc. annual Return On Equity for 2022 was -135 %, a 186% decline from 2021.
  • Nuo Therapeutics, Inc. annual Return On Equity for 2021 was 156 %, a 1424% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -347 -52.4 -17.8% Jul 1, 2024 Sep 30, 2024
Q2 2024 -399 -198 -98.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 -471 -328 -230% Jan 1, 2024 Mar 31, 2024
Q4 2023 -355 -220 -164% Oct 1, 2023 Dec 31, 2023
Q3 2023 -294 -181 -159% Jul 1, 2023 Sep 30, 2023
Q2 2023 -201 -88.5 -78.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -143 +86.5 +37.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -135 -290 -186% Oct 1, 2022 Dec 31, 2022
Q3 2022 -114 -180 -272% Jul 1, 2022 Sep 30, 2022
Q2 2022 -113 -154 -377% Apr 1, 2022 Jun 30, 2022
Q1 2022 -229 -265 -732% Jan 1, 2022 Mar 31, 2022
Q4 2021 156 +146 +1424% Oct 1, 2021 Dec 31, 2021
Q3 2021 66.2 +85 Jul 1, 2021 Sep 30, 2021
Q2 2021 40.8 +51.8 Apr 1, 2021 Jun 30, 2021
Q1 2021 36.3 +7.76 +27.2% Jan 1, 2021 Mar 31, 2021
Q4 2020 10.2 -98.5 -90.6% Oct 1, 2020 Dec 31, 2020
Q3 2020 -18.9 -127 -117% Jul 1, 2020 Sep 30, 2020
Q2 2020 -11 -236 -105% Apr 1, 2020 Jun 30, 2020
Q1 2020 28.5 -348 -92.4% Jan 1, 2020 Mar 31, 2020
Q4 2019 109 -441 -80.2% Oct 1, 2019 Dec 31, 2019
Q3 2019 108 -7.01K -98.5% Jul 1, 2019 Sep 30, 2019
Q2 2019 225 +725 Apr 1, 2019 Jun 30, 2019
Q1 2019 376 +732 Jan 1, 2019 Mar 31, 2019
Q4 2018 550 +775 Oct 1, 2018 Dec 31, 2018
Q3 2018 7.12K Jul 1, 2018 Sep 30, 2018
Q2 2018 -501 Apr 1, 2018 Jun 30, 2018
Q1 2018 -356 Jan 1, 2018 Mar 31, 2018
Q4 2017 -225 Oct 1, 2017 Dec 31, 2017
Q3 2016 435 +487 Jul 1, 2016 Sep 30, 2016
Q2 2016 448 +440 +5625% May 5, 2016 Jun 30, 2016
Q1 2016 465 +522 Jan 1, 2016 Mar 31, 2016
Q4 2015 -2.6K -2.49K -2258% Oct 1, 2015 Dec 31, 2015
Q3 2015 -51.5 +83 +61.7% Jul 1, 2015 Sep 30, 2015
Q2 2015 7.82 +118 Apr 1, 2015 Jun 30, 2015
Q1 2015 -57.8 +12.5 +17.8% Jan 1, 2015 Mar 31, 2015
Q4 2014 -110 -48.9 -79.6% Oct 1, 2014 Dec 31, 2014
Q3 2014 -134 -81 -151% Jul 1, 2014 Sep 30, 2014
Q2 2014 -110 -63.2 -134% Apr 1, 2014 Jun 30, 2014
Q1 2014 -70.3 -19.5 -38.5% Jan 1, 2014 Mar 31, 2014
Q4 2013 -61.5 -1.23 -2.04% Oct 1, 2013 Dec 31, 2013
Q3 2013 -53.5 +8.83 +14.2% Jul 1, 2013 Sep 30, 2013
Q2 2013 -47 +47.6 +50.3% Apr 1, 2013 Jun 30, 2013
Q1 2013 -50.8 +113 +69% Jan 1, 2013 Mar 31, 2013
Q4 2012 -60.3 Oct 1, 2012 Dec 31, 2012
Q3 2012 -62.4 Jul 1, 2012 Sep 30, 2012
Q2 2012 -94.6 Apr 1, 2012 Jun 30, 2012
Q1 2012 -164 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.